Aura Biosciences, Inc.

NASDAQ (USD): Aura Biosciences, Inc. (AURA)

Last Price

8.23

Today's Change

+0.05 (0.61%)

Day's Change

8.039 - 8.33

Trading Volume

81,046

Profile
AURA

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Elisabet de los Pinos Ph.D. Dr. Elisabet de los Pinos Ph.D.

Full Time Employees:  88 88

IPO Date:  2021-10-29 2021-10-29

CIK:  0001501796 0001501796

ISIN:  US05153U1079 US05153U1079

CUSIP:  05153U107 05153U107

Beta:  0.33 0.33

Last Dividend:  0.00 0.00

Dcf Diff:  7.64 7.64

Dcf:  0.54 0.54

Description

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Address

85 Bolton Street,
Cambridge, MA 02140, US

617 500 8864

http://www.aurabiosciences.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment